Eliem Therapeutics Inc (ELYM)
7.47
-0.40
(-5.08%)
USD |
NASDAQ |
May 23, 16:00
7.47
0.00 (0.00%)
After-Hours: 17:16
Eliem Therapeutics Enterprise Value: 123.92M for May 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 22, 2024 | 123.92M |
| May 21, 2024 | 123.04M |
| May 20, 2024 | 133.52M |
| May 17, 2024 | 134.97M |
| May 16, 2024 | 132.94M |
| May 15, 2024 | 127.41M |
| May 14, 2024 | 133.23M |
| May 13, 2024 | 139.63M |
| May 10, 2024 | 141.08M |
| May 09, 2024 | 155.34M |
| May 08, 2024 | 153.35M |
| May 07, 2024 | 177.75M |
| May 06, 2024 | 134.78M |
| May 03, 2024 | 176.50M |
| May 02, 2024 | 127.57M |
| May 01, 2024 | 104.84M |
| April 30, 2024 | 91.53M |
| April 29, 2024 | 34.14M |
| April 26, 2024 | 5.310M |
| April 25, 2024 | -11.05M |
| April 24, 2024 | -3.562M |
| April 23, 2024 | -1.067M |
| April 22, 2024 | 2.260M |
| April 19, 2024 | 1.706M |
| April 18, 2024 | 10.85M |
| Date | Value |
|---|---|
| April 17, 2024 | 17.79M |
| April 16, 2024 | 21.39M |
| April 15, 2024 | 26.66M |
| April 12, 2024 | 14.46M |
| April 11, 2024 | 21.94M |
| April 10, 2024 | -31.01M |
| April 09, 2024 | -30.45M |
| April 08, 2024 | -30.45M |
| April 05, 2024 | -32.95M |
| April 04, 2024 | -27.68M |
| April 03, 2024 | -28.24M |
| April 02, 2024 | -27.13M |
| April 01, 2024 | -27.40M |
| March 28, 2024 | -30.85M |
| March 27, 2024 | -30.29M |
| March 26, 2024 | -31.68M |
| March 25, 2024 | -30.02M |
| March 22, 2024 | -28.91M |
| March 21, 2024 | -31.14M |
| March 20, 2024 | -29.48M |
| March 19, 2024 | -29.76M |
| March 18, 2024 | -28.93M |
| March 15, 2024 | -31.97M |
| March 14, 2024 | -32.25M |
| March 13, 2024 | -28.69M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-62.46M
Minimum
Feb 16 2023
806.24M
Maximum
Sep 07 2021
45.73M
Average
-28.94M
Median
Jul 21 2023
Enterprise Value Benchmarks
| Alpine Immune Sciences Inc | 4.151B |
| Candel Therapeutics Inc | 308.71M |
| Cyclacel Pharmaceuticals Inc | 0.3071M |
| Lipocine Inc | 10.66M |
| GlycoMimetics Inc | -13.08M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.697M |
| Total Expenses (Quarterly) | 3.005M |
| EPS Diluted (Quarterly) | -0.06 |
| Earnings Yield | -7.10% |